Location
Philadelphia, PA
Start Date
17-4-2026 1:30 PM
End Date
17-4-2026 2:30 PM
Description
Introduction: Hallucinations, delusions, and thought disorganization are hallmark features of schizophrenia; however, these symptoms are not pathognomonic and may occur in a variety of neurological conditions. Current guidelines from the American Psychiatric Association during initial evaluation of psychosis recommend comprehensive psychiatric assessment and medical history, but routine neuroimaging is not considered standard of care in typical presentations. Failure to adequately investigate organic causes may result in delayed diagnosis and suboptimal treatment. In cases of atypical features or poor response to antipsychotics, clinicians should broaden the differential diagnosis and reconsider underlying neurological etiologies.
Methods: A narrative literature review was conducted to examine reported cases and reviews describing misdiagnosis of schizophrenia in patients ultimately diagnosed with neurological disorders. Findings were synthesized to identify recurring themes and clinical implications for earlier neurological evaluation.
Results: Organic conditions may produce delusions, hallucinations, and cognitive impairment that mimic primary psychotic disorders but are detectable through neurological examination and neuroimaging.
Three key neurological disorders frequently identified as schizophrenia mimickers include epilepsy, multiple sclerosis (MS), autoimmune encephalitis.
Epilepsy, particularly seizures originating within the temporal or frontal lobes, can present with psychotic symptoms. The most common manifestation is postictal psychosis, characterized by agitation, delusions, and hallucinations 12-120 hours post seizure. Unlike schizophrenia, psychosis associated with epilepsy has a clear temporal relationship to seizure activity. During these episodes, patients may exhibit increased risk of self-harm, suicide, and interpersonal violence. Optimizing seizure control is therefore critical, as effective management may prevent occurrence of postictal psychosis and improve overall patient and public safety.
Psychosis may rarely present as the initial or sole manifestation of MS, with some patients experiencing diagnostic delays averaging 5–10 years prior to neuroimaging confirmation. Presentations can include hallucinations, delusions, and catatonia. In such cases, immunomodulatory therapy has demonstrated greater efficacy in symptom resolution compared to antipsychotic treatment alone, highlighting the importance of identifying the underlying demyelinating process.
Autoimmune encephalitis often presents with rapidly progressive psychosis, cognitive decline, and functional deterioration. It is commonly described in young women, sometimes in association with ovarian tumors. Clinical features that may differentiate autoimmune encephalitis from schizophrenia include visual hallucinations and lower baseline functioning. Schizophrenia is more associated with prior history of mental illness, verbal hallucinations, and delusional self-experience. Early recognition and treatment with corticosteroids or intravenous immunoglobulin significantly improve outcomes and survival in these patients.
Conclusion: Misdiagnosis of schizophrenia in the context of underlying neurological disorders can lead to prolonged morbidity and delayed definitive treatment. Tailoring management to the primary neurological condition often results in improved psychiatric outcomes. While obtaining comprehensive neurological evaluation in acutely psychotic patients may be challenging, clinicians have a responsibility to investigate red flags and reassess diagnoses in cases of atypical presentation or treatment resistance. Future clinical guidelines should consider emphasizing earlier neurological assessment and a lower threshold for neuroimaging in first-episode or atypical psychosis.
Embargo Period
6-3-2026
Included in
Exploring the Misdiagnosis of Schizophrenia in the Setting of Underlying Neurological Disorders
Philadelphia, PA
Introduction: Hallucinations, delusions, and thought disorganization are hallmark features of schizophrenia; however, these symptoms are not pathognomonic and may occur in a variety of neurological conditions. Current guidelines from the American Psychiatric Association during initial evaluation of psychosis recommend comprehensive psychiatric assessment and medical history, but routine neuroimaging is not considered standard of care in typical presentations. Failure to adequately investigate organic causes may result in delayed diagnosis and suboptimal treatment. In cases of atypical features or poor response to antipsychotics, clinicians should broaden the differential diagnosis and reconsider underlying neurological etiologies.
Methods: A narrative literature review was conducted to examine reported cases and reviews describing misdiagnosis of schizophrenia in patients ultimately diagnosed with neurological disorders. Findings were synthesized to identify recurring themes and clinical implications for earlier neurological evaluation.
Results: Organic conditions may produce delusions, hallucinations, and cognitive impairment that mimic primary psychotic disorders but are detectable through neurological examination and neuroimaging.
Three key neurological disorders frequently identified as schizophrenia mimickers include epilepsy, multiple sclerosis (MS), autoimmune encephalitis.
Epilepsy, particularly seizures originating within the temporal or frontal lobes, can present with psychotic symptoms. The most common manifestation is postictal psychosis, characterized by agitation, delusions, and hallucinations 12-120 hours post seizure. Unlike schizophrenia, psychosis associated with epilepsy has a clear temporal relationship to seizure activity. During these episodes, patients may exhibit increased risk of self-harm, suicide, and interpersonal violence. Optimizing seizure control is therefore critical, as effective management may prevent occurrence of postictal psychosis and improve overall patient and public safety.
Psychosis may rarely present as the initial or sole manifestation of MS, with some patients experiencing diagnostic delays averaging 5–10 years prior to neuroimaging confirmation. Presentations can include hallucinations, delusions, and catatonia. In such cases, immunomodulatory therapy has demonstrated greater efficacy in symptom resolution compared to antipsychotic treatment alone, highlighting the importance of identifying the underlying demyelinating process.
Autoimmune encephalitis often presents with rapidly progressive psychosis, cognitive decline, and functional deterioration. It is commonly described in young women, sometimes in association with ovarian tumors. Clinical features that may differentiate autoimmune encephalitis from schizophrenia include visual hallucinations and lower baseline functioning. Schizophrenia is more associated with prior history of mental illness, verbal hallucinations, and delusional self-experience. Early recognition and treatment with corticosteroids or intravenous immunoglobulin significantly improve outcomes and survival in these patients.
Conclusion: Misdiagnosis of schizophrenia in the context of underlying neurological disorders can lead to prolonged morbidity and delayed definitive treatment. Tailoring management to the primary neurological condition often results in improved psychiatric outcomes. While obtaining comprehensive neurological evaluation in acutely psychotic patients may be challenging, clinicians have a responsibility to investigate red flags and reassess diagnoses in cases of atypical presentation or treatment resistance. Future clinical guidelines should consider emphasizing earlier neurological assessment and a lower threshold for neuroimaging in first-episode or atypical psychosis.